GH · Guardant Health Inc
Price
Snapshot
50 fields · last close| Market Cap | $21.61B |
| P/E | — |
| Float | 128.0M |
| Beta | 1.73 |
| Volatility | 43.3% |
| Exchange | NASDAQ |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | High |
| Clavix score | 64 |
| Price | 155.34 |
| Change | −3.54% |
| Prev Close | 161.04 |
| Open | 164.09 |
| Day Low | 159.59 |
| Day High | 166.42 |
| Avg Vol | 2 |
| Avg $ Vol | $310.3M |
| 52W High | 176.58 |
| 52W Low | 53.40 |
| 52W Pos | 82.8% |
| From High | −12.03% |
| From Low | +190.90% |
| Max DD 1Y | −32.98% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −5.36% |
| SMA 50 | −2.39% |
| SMA 200 | +32.70% |
| RSI (14) | 49.8 |
| Vol 30D | 46.5% |
| Vol 90D | 56.8% |
| 1Y Range | 53–177 |
| Daily bars | 506 |
| Perf Week | −4.44% |
| Perf Month | −1.31% |
| Perf Quarter | +21.03% |
| Perf Half Y | +73.95% |
| Perf Year | +147.53% |
| Perf YTD | +52.68% |
| Prev Day | −3.54% |
| Clavix | C+ |
| Debt / Eq | 7.18 |
| Curr Ratio | 4.84 |
| Int Cover | -0.8× |
| FCF Margin | — |
| Rev Growth | +44.3% |
| Profit | Unprofitable |
| Leverage | Very High |
| Sector rank | 42 / 47 |
Clavix risk grade
regraded every trading dayGH grades C+, 64 of 100. Steadiest on News Sentiment (68), most exposed on Price Stability (45, fragile). 2 of the 4 weighted dimensions sit above the Health Care median. Ranks 42 of 47 in Health Care by Clavix score.
How rough the ride is
| GH | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.73 | 0.81 |
| Volatilityannualized | 43.3% | 20.4% |
| Max drawdown, past yearworst peak-to-trough fall | −33.0% | — |
| Typical daily movemedian absolute daily change | 1.80% | — |
| Days beyond ±3%of the last 252 sessions | 7731% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| GH | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.73 | 0.81 |
| Macro sensitivityrate, dollar and credit exposure bucket | High | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| GH | |
|---|---|
| 1 week | −4.4% |
| 1 month | −1.3% |
| Year to date | +52.7% |
| 1 year | +147.5% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| GH | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 29 Jul |
| Average score0 most bearish, 100 most bullish | 50 |
| Bullish · bearisharticles above 60 · below 40 | 15 · 13 |
| Directionarticles whose tone is improving vs worsening | 15 ↑ 13 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| GH | |
|---|---|
| Revenue growthyear over year | +44.3% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Health Care
47 companies| Metric | GH | Sector spread | Median |
|---|---|---|---|
| Beta | 1.73 | 0.81 | |
| Volatility | 43.3% | 20.4% | |
| Debt / equity | 7.18 | 0.71 | |
| Current ratio | 4.84 | 1.58 | |
| Interest coverage | -0.8× | 6.3× |
Recent news
most recent scored articles · the chip is the article’s score · click to openGuardant Health saw unusually high trading in put options on Friday, with 4,283 puts purchased, about 311% above the typical daily volume of around 1,043. The article does not identify a reason for the spike.
A federal judge in Delaware refused to dismiss a patent infringement lawsuit Guardant Health filed against Tempus AI. The patents at issue cover technology used to analyze cancer-related genetic data to help guide testing and treatment decisions.
Guardant Health's stock has gained about 327.6% over three years, but mixed valuation signals and a recent legal setback in a patent appeal suggest shares could trade at roughly a 21% discount to their current price.
A U.S. district court ruled in August 2026 that Guardant Health infringed DNA sequencing patents held by TwinStrand Biosciences and the University of Washington, ordering more than US$245.2 million in damages, accrued royalties and interest, plus ongoing royalties on 11 products through March 2033. The company says it will appeal and notes that updated versions of its Guardant Reveal and Shield tests are excluded from the royalty order.
A U.S. district court ordered Guardant Health to pay more than US$245.2 million in a patent dispute with TwinStrand Biosciences and the University of Washington. Despite this, the stock has been volatile but still up 17.5% over the past month and 68.0% year to date, with a one-year total return of about 169%.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| THC | Tenet Healthcare Corp | B- | $21.22B | 9.47 | 1.22 | Compare |
| STE | STERIS plc | A- | $22.12B | 27.69 | 0.88 | Compare |
| ZBH | Zimmer Biomet Holdings, Inc | B+ | $18.37B | 23.50 | 0.50 | Compare |
| DGX | Quest Diagnostics Inc | A- | $26.42B | 24.97 | 0.56 | Compare |
| LH | Labcorp Holdings Inc | A- | $26.88B | 26.91 | 0.88 | Compare |
| ALC | Alcon AG | B+ | $29.66B | 44.75 | 1.12 | Compare |
| SOLV | Solventum Corp | B+ | $15.74B | 10.26 | 0.72 | Compare |
| GEHC | GE Healthcare Technologies Inc | B- | $31.49B | 16.79 | 0.82 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.